In Brief: LifeScan v. Polymer Technology
This article was originally published in The Gray Sheet
Executive Summary
LifeScan v. Polymer Technology: Polymer files "notice of appeal" June 1 in its ongoing patent dispute with Johnson & Johnson's LifeScan subsidiary over Polymer's right to manufacture and sell First Choice glucose test strips, which are designed for use with LifeScan's One Touch glucose meter. The appeal, which will be heard in the Court of Appeals for the Federal Circuit in Washington, D.C., will seek to overturn a May 31 ruling by the U.S. District Court for Western Washington enjoining Polymer from making or selling the off-brand test strip ("The Gray Sheet" June 5, p. 20)...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.